In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities
- 1 July 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (7) , 704-707
- https://doi.org/10.1046/j.1469-0691.2003.00572.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antimicrobial resistance in Streptococcus pyogenes isolates in BerlinJournal of Antimicrobial Chemotherapy, 2000
- High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998Journal of Antimicrobial Chemotherapy, 2000
- Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolatesJournal of Antimicrobial Chemotherapy, 2000
- Macrolide resistance in group A streptococciJournal of Antimicrobial Chemotherapy, 2000
- Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in FranceJournal of Antimicrobial Chemotherapy, 1999
- Erythromycin-Resistant Neisseria gonorrhoeae and Oral Commensal Neisseria spp. Carry Known rRNA Methylase GenesAntimicrobial Agents and Chemotherapy, 1999
- A variety of Gram-positive bacteria carry mobile mef genesJournal of Antimicrobial Chemotherapy, 1999
- Streptococcus py o genesIsolated in Portugal: Macrolide Resistance Phenotypes and Correlation with T TypesMicrobial Drug Resistance, 1999
- Erythromycin Resistance Genes in Group A Streptococci in FinlandAntimicrobial Agents and Chemotherapy, 1999
- Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJournal of Antimicrobial Chemotherapy, 1993